Back to Search
Start Over
Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).
- Source :
- Cell Cycle; Nov2012, Vol. 11 Issue 21, p4020-4032, 13p
- Publication Year :
- 2012
Details
- Language :
- English
- ISSN :
- 15384101
- Volume :
- 11
- Issue :
- 21
- Database :
- Complementary Index
- Journal :
- Cell Cycle
- Publication Type :
- Academic Journal
- Accession number :
- 83079324
- Full Text :
- https://doi.org/10.4161/cc.22225